2010;55:1067 75. 61. Hoffman SN, TenBrook JA, Wolf MP, et al. A meta-analysis of random- ized controlled trials comparing coronary artery bypass graft with percu- taneous transluminal coronary angioplasty: one- to eight-year outcomes. J Am Coll Cardiol. 2003;41:1293 304. 62. Hueb W, Lopes NH, Gersh BJ, et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clini- cal trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2007;115:1082 9. 63. Malenka DJ, Leavitt BJ, Hearne MJ, et al. Comparing long-term sur- vival of patients with multivessel coronary disease after CABG or PCI: analysis of BARI-like patients in northern New England. Circulation. 2005;112:I371 6. Fihn et al 2014 Stable Ischemic Heart Disease Focused Update 1761 64. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabe- tes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol. 2001;37:1008 15. 65. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol. 1998;31:10 9. 66. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360:961 72. 67. Deleted in press. 68. Farkouh ME, Domanski M, Sleeper LA, et al. Strategies for mul- tivessel revascularization in patients with diabetes. N Engl J Med. 2012;367:2375 84. 69. Hannan EL, Racz MJ, Walford G, et al. Long-term outcomes of coro- nary-artery bypass grafting versus stent implantation. N Engl J Med. 2005;352:2174 83. 70. Hannan EL, Wu C, Walford G, et al. Drug-eluting stents vs. coronary- artery bypass grafting in multivessel coronary disease. 